MCSs are multipotent progenitor cells capable of developing into a variety of cell types during human development, including adipocytes, chondrocytes, osteocytes, and cardiomyocytes. Population aging and an increasing prevalence of chronic disease are driving interest in MSC-based therapies. Over the past 150 years, the average human lifespan has doubled and continued increases in life-expectancy are expected. [Read more…]
Sanatela AT Medical Solutions Inc. Announces Groundbreaking Patent Issuance for Cancer Stem Cell Identification and Precision Treatment Platform
Rochester, NY, September 24, 2025 – After two decades of pioneering hematology and cancer stem cell research, Sanatela AT Medical Solutions Inc. proudly announces that the United States Patent and Trademark Office (USPTO) has officially issued its long-awaited patent for a revolutionary cancer detection and treatment platform. [Read more…]
BioEden: How Dental Stem Cells Will Impact Our Future
In this interview with Tony Veverka, Chief Group Executive of BioEden, Mr. Veverka discusses how dental stem cells will impact our future. BioEden is a global stem cell storage company with laboratories in the UK and USA and sales operations in 19 countries. BioEden is also the world’s first international biobank company to collect, assess, and cryogenically store living stem cells from deciduous baby teeth.
How To (Potentially) Avoid ACL Surgery With Stem Cell Treatment
Despite ACL surgeries being more readily available than ever before, torn knee ligaments are still one of the most dreaded injuries for athletes and other active people. The anterior cruciate ligament (ACL) is responsible for stabilizing the knee. If it tears after a sudden wrenching movement, then stability and ease of motion are destroyed. Until recently, ACL surgeries seemed to be the only way for patients to escape the pain, stiffness, and stability loss that comes with an ACL injury.
Fortunately, stem cell treatment may now represent a viable way for some patients to repair torn knee ligaments while avoiding invasive ACL surgeries.
Alternative To ACL Injuries? How Stem Cells Might Help
In this article:
Interview With Kaz Hirao, President & COO at Fujifilm Cellular Dynamics
Fujifilm CDI is the largest provider of induced pluripotent stem cell (“iPSC” or “iPS cell”) products worldwide. In addition to being a global leader for life science products, CDI divided into two business units (Life Science and Therapeutics), positioning it to further invest in the development of iPSC-derived cell therapeutics.
The company also opened a $21M cGMP production facility to support its internal cell therapeutics pipeline, as well as serve as a CDMO for iPS cell products.
- « Previous Page
- 1
- …
- 44
- 45
- 46
- 47
- 48
- …
- 338
- Next Page »